Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)
Industry: Healthcare

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices for the treatment of cardiopulmonary diseases. The company offers INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and has completed Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Its products are also used for other pulmonary hypertension conditions. The company was founded in 2009 and is headquartered in Warren, New Jersey.

Current Quote*
Last: $0.930
Change: -0.010
Book: $Unk
Volume: 20,173

As Of: 11/21 11:31 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol BLPH

Graphs for BLPH

3 Month Graph

6 Month Graph

1 Year Graph